Which of the following is an FDA-approved indication for labetalol Hcl?

A. Flexeril is the brand name for cyclobenzaprine hydrochloride, a skeletal muscle relaxant. It acts on the locus coeruleus to reduce tonic somatic motor activity. It does not possess the antimetabolite properties characteristic of the drug methotrexate specified in the question.

B. Xalatan is the brand name for latanoprost, a prostaglandin F2-alpha analog used in ophthalmology. It increases uveoscleral outflow to reduce intraocular pressure. It is not chemically or therapeutically related to the folic acid antagonist methotrexate mentioned in the question stem.

C. Trexall is a proprietary brand name for methotrexate, an antimetabolite and antifolate agent. It competitively inhibits dihydrofolate reductase, preventing the conversion of dihydrofolate to tetrahydrofolate. This action disrupts DNA synthesis and cellular replication in neoplastic and inflammatory cells.

D. Zanaflex is the brand name for tizanidine, a central alpha-2 adrenergic agonist used for spasticity. It increases presynaptic inhibition of motor neurons to reduce muscle tone. It lacks the immunosuppressive and cytotoxic mechanisms of action that define the molecule methotrexate.

A. Levofloxacin is indicated for complicated urinary tract infections, including pyelonephritis, caused by susceptible Gram-negative bacilli like Escherichia coli. It achieves high renal concentrations, effectively inhibiting bacterial DNA gyrase and topoisomerase 4. This bactericidal action is essential for treating deep-seated renal parenchyma infections.

B. Tetanus is caused by the toxin tetanospasmin from Clostridium tetani, requiring metronidazole or penicillin G for antimicrobial therapy. Levofloxacin is not an FDA-approved treatment for this neurological condition. The management primarily involves wound debridement, antitoxin administration, and supportive care for muscle spasms.

C. Herpes zoster is a viral infection resulting from the reactivation of the varicella-zoster virus within sensory ganglia. Levofloxacin is a fluoroquinolone antibiotic and possesses no inhibitory activity against viral DNA polymerase. Antiviral agents like acyclovir or valacyclovir are the standard pharmacological interventions for this condition.

D. This agent is FDA-approved for community-acquired pneumonia due to its broad-spectrum activity against Streptococcus pneumoniae and atypical pathogens. It provides excellent lung tissue penetration and inhibits the supercoiling of bacterial DNA. The question stem targets specific labeled indications, which include this respiratory infection.